Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19

Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19

Abstract Neurological long-term sequelae are increasingly considered an important challenge in the recent COVID-19 pandemic. However, most evidence for neurological symptoms after SARS-CoV-2 infection and central nervous system invasion of the virus stems from individuals severely affected in the ac...

Full description

Bibliographic Details
Main Authors: Max Borsche, Dirk Reichel, Anja Fellbrich, Anne S. Lixenfeld, Johann Rahmöller, Eva-Juliane Vollstedt, Bandik Föh, Alexander Balck, Christine Klein, Marc Ehlers, Andreas Moser
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Neurological Research and Practice
Subjects:
COVID-19
SARS-CoV-2
Neurologic sequelae
Cognitive impairment
CSF antibodies
Online Access:https://doi.org/10.1186/s42466-021-00135-y

Internet

https://doi.org/10.1186/s42466-021-00135-y

Similar Items